An interventional study of Self-Compassion Program in Nomophobia, sponsored by University of Beykent. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-16.
Sponsored by University of Beykent · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,722 studies in Pain with a site in Turkey — 321 open to participants now, 374 under way, none of them phase 3. Pain · Turkey.
Among the 1,722 studies in Pain with a site in Turkey, this one is the 178th largest by planned enrollment of the 1,499 interventional ones that give a count, is one of 283 that started in 2025, is one of 1,457 with no phase, reaches primary completion later than 130 of the 373 other live ones, and was the 1,276th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →321 of the 1,722 studies in Pain with a site in Turkey are open now. Recruiting first, the newest first:
Mersin University · Sites in Turkey
Ages 18+
Artvin Coruh University · Sites in Turkey
Ages 6–12
Mersin University · Sites in Turkey
Ages 18+
Bahçeşehir University · Sites in Turkey
Ages 45–65
Istanbul University · Sites in Turkey
Ages 1–12
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,722 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 6 · Phase 4 34
First in 2006; this study’s year is marked. 283 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 70 across the 1,499 interventional studies, 84 across the 223 observational. Of the 1,276 that completed or were terminated, 7 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 1,722 have an industry lead sponsor. The 10 most frequent:
University of Beykent is the lead sponsor of 56 studies on the registry; 15 are open to participants now.
University of Beykent has 5 studies filed under Pain — fewer than ten, so there is no comparison to draw.
90 of the studies in Pain with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404163Tarsus UniversityWalkway Used in Postoperative Mobilization | 2026-11-30 |
| NCT07915804Istanbul UniversityPerfusion Index for Postoperative Pain Assessment in Pediatric Adenotonsillectomy | 2026-11-30 |
| NCT07892196Antalya Training and Research HospitalDoes Chronic Pain Change Over Time in Children With Duchenne Muscular Dystrophy? | 2026-11-30 |
| NCT07936604Harran UniversityMotor Control Exercise and Myofascial Release in Greater Trochanteric Pain Syndrome | 2026-11-30 |
| NCT07656207Gaziantep Islam Science and Technology UniversityThe Effect of Skin-to-skin Contact at Birth | 2026-12 |
Add all 90 to your calendar (.ics) → With an account.
Among the 1,722 studies in Pain with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The term nomophobia, which can also be defined as a symptom, has emerged with the excessive use of smartphones. Nomophobia is the anxiety and fear that people feel when they are away from their phones for any reason. Nomophobia is defined as the "fear of being deprived of phone or internet access." According to DSM5, "situational phobias are excessive, irrational fears accompanied by anxiety and distress towards a specific object or situation." Considering the anxiety, stress, and worry it creates on individuals, Bragazzi and Del Puente (2014) stated that nomophobia should be added to the DSM-5 due to the dimensions of the anxiety, stress, and worry it creates on individuals and the speed at which it spreads. They explained the symptoms of nomophobia as follows; spending most of the day with a smartphone, constantly checking the battery, in case of being away from the smartphone, thoughts such as the battery or credit running out and not being able to find the phone create anxiety in individuals, staying away from places and spaces where it is not possible to use a smartphone, constantly checking whether notifications or messages have arrived, keeping the smartphone on and nearby even while sleeping, communicating using digital tools because face-to-face conversation creates anxiety, incurring extraordinary expenses for a smartphone or getting into excessive debt.
In addition to making life easier, nomophobia, which occurs with excessive and uncontrolled use of smartphones, can cause some problems. Increasing individuality and the resulting weakening of face-to-face communication bring about addictive applications, depression, headache, visual impairments, sleep problems, musculoskeletal problems, and physiological and psychological problems.
To cope with and manage the symptoms of an addictive condition such as nomophobia, it is envisaged that young adults should be supported with self-compassion practices.
Self-compassion exists from the essence of awareness when we encounter painful and distressing situations. Self-compassion tells individuals to be kind to themselves when they encounter pain and distress. When people encounter an adverse life event, they blame themselves, criticize themselves, react to themselves, and make harmful decisions. A happy and peaceful life emerges thanks to self-compassion, a sense of security, and health. If individuals can accept and tolerate many positive and negative life events and be kind and tolerant towards themselves, they can stop limiting and ignoring their feelings and thoughts. In this way, they can avoid over-identifying by realizing that the experiences experienced are experiences that many people can experience. Individuals with high levels of self-compassion have low levels of depression, anxiety, stress, perfectionism, rumination, and suppressing thoughts. In addition, since they do not judge themselves, their happiness, optimism, enjoyment of life, and motivation are high. In line with this information, self-compassion practices can be supportive during this period when young adults encounter a problem such as nomophobia and have to manage many physiological symptoms. This study aimed to determine the effect of self-compassion practices on nomophobia symptoms in young adults.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group will be given an online self-compassion program for 8 weeks..
Behavioral: Self-Compassion Program
There will be no intervention
Program includes four basic practices: breathing meditation, walking meditation, body scan, and mindful movement. Consciously focusing on what is happening allows people to observe and accept what they are experiencing in their bodies, minds, and the world around them at that moment. Mindfulness practices are an 8-week practice consisting of 2-2.5 hour sessions per week by a trained instructor, mindfulness meditation practices, yoga practices, examining the psychological and physiological aspects of stress, and recently including the concept of self-compassion. In addition, daily practices are given to participants, and a suitable day is determined as a retreat day. The aim is to enable individuals to reveal and experience their thoughts, emotions, and bodily sensations and to increase emotional tolerance by revealing avoidance behaviors. Individuals learn to return to and accept intense bodily sensations and emotional discomfort with mindfulness.
Nomophobia Scale
File Nomophobia Scale by Yıldırım and Correia (2015) consists of 20 items. The scale is answered from 1 (Strongly Disagree) to 7 (Strongly Agree). The scale is a 7-point Likert type. It consists of 4 sub-dimensions: "Inability to Access Information" (4 items), "Sacrificing Comfort" (5 items), "Inability to Communicate" (6 items) and "Losing Online Connection" (5 items) (Yıldırım and Correia, 2015). Participants are between 20 and 140 on the Nomophobia Scale. It is seen that participants with less than 20 points do not have nomophobia and those with 100-14 points have extreme nomophobia. The original systems of the scale were calculated as .95. The reliability in this study was based on Cronbach's alpha value of .95.
Time frame: To be filled after the 8-week training program is completed
Self-Compassion Scale Short Form (SCF-K)
Self-Compassion Scale Short Form (SCF-K); The scale developed by Raes, Pommier, Neff, and Van Gucht (2011) considering it to be more convenient than the long form in terms of time was used. SCF-K, consisting of items taken from the 26-item Self-Compassion Scale, included two items for each subcomponent of self-compassion in order to create this short form, and there are 12 items in total. It is seen that the scale has started to be used in Western literature in recent years, especially due to its ease of use. The Turkish adaptation of the Self-Compassion Scale Short Form was made by Yıldırım and Sarı (2018).
Time frame: To be filled after the 8-week training program is completed
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Aug 2025; primary completion for Oct 2025, 2 months later.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Beykent